Appendix B: Sources of evidence considered by the Committee

Appendix B: Sources of evidence considered by the Committee

The diagnostics assessment report for this evaluation was prepared by the Kleijnen Systematic Reviews Ltd Assessment Group.

  • Westwood M, Joore M, Grutters J. et al. Contrast enhanced ultrasound using SonoVue (sulphur hexafluoride microbubbles), compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging, for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. January 2012.

Registered stakeholders

Registered stakeholders were recruited from the following organisations but do not necessarily represent the views of that organisation. They were invited to attend the scoping workshop and to comment on the diagnostics assessment report and the diagnostics consultation document.

Manufacturers/sponsors:

Technology under consideration

  • Bracco UK Ltd

Comparator(s)

  • None

Other

  • GE Healthcare

Professional/specialist and patient/carer groups:

  • Royal College of Nursing

  • British Medical Ultrasound Society

  • Echocardiography Department, Princess Royal University Hospital, London

  • Gateshead Health NHS Foundation Trust

  • British Liver Trust

  • British Society of Gastrointestinal and Abdominal Radiology

  • Peterborough City Hospital

  • National Institute for Health and Care Excellence (NICE)